London\/Bielefeld \u2014 Arcus Infra\u00adstruc\u00adture Part\u00adners (\u201cArcus\u201d), an invest\u00adment firm specia\u00adli\u00adzing in infra\u00adstruc\u00adture invest\u00adments, has acqui\u00adred SK Pharma Logi\u00adstics GmbH (\u201cSK Pharma\u201d), a provi\u00adder of logi\u00adstics solu\u00adti\u00adons for the health\u00adcare indus\u00adtry in Germany, through its Arcus Euro\u00adpean Infra\u00adstruc\u00adture Fund 4. SK Pharma\u2019s exis\u00adting manage\u00adment team will retain a stake in the company. The tran\u00adsac\u00adtion is still subject to the custo\u00admary regu\u00adla\u00adtory appr\u00adovals and is expec\u00adted to close in the fourth quar\u00adter of 2026. POELLATH provi\u00added legal coun\u00adsel to SK Pharma\u2019s manage\u00adment regar\u00adding a manage\u00adment equity stake as part of the transaction. <\/p>\n
SK Pharma, based in Biele\u00adfeld, is one of the leading specia\u00adli\u00adzed logi\u00adstics provi\u00adders for the health\u00adcare indus\u00adtry in Germany. With a network of eight warehouse loca\u00adti\u00adons in northwes\u00adtern Germany, the company has appro\u00adxi\u00adm\u00adately 85,000 m\u00b2 of tempe\u00adra\u00adture-control\u00adled warehouse space and more than 100,000 pallet spaces. SK Pharma\u2019s custo\u00admer base includes phar\u00admaceu\u00adti\u00adcal manu\u00adfac\u00adtu\u00adr\u00aders, importers, whole\u00adsa\u00adlers, and other compa\u00adnies in the health\u00adcare sector. In addi\u00adtion to its GMP- and GDP-compli\u00adant warehousing and distri\u00adbu\u00adtion infra\u00adstruc\u00adture, the company offers a wide range of comple\u00admen\u00adtary services and enables close opera\u00adtio\u00adnal, regu\u00adla\u00adtory, and digi\u00adtal inte\u00adgra\u00adtion with its custo\u00admers\u2019 proces\u00adses. The German market for outsour\u00adced phar\u00admaceu\u00adti\u00adcal logi\u00adstics is expe\u00adri\u00aden\u00adcing struc\u00adtu\u00adral growth, driven by demo\u00adgra\u00adphic trends, incre\u00adasing outsour\u00adcing, and rising regu\u00adla\u00adtory requi\u00adre\u00adments. With its specia\u00adli\u00adzed infra\u00adstruc\u00adture and many years of indus\u00adtry exper\u00adtise, SK Pharma is excep\u00adtio\u00adnally well-posi\u00adtio\u00adned in this market. <\/p>\n
Arcus is an inde\u00adpen\u00addent invest\u00adment firm focu\u00adsed on mid-sized infra\u00adstruc\u00adture compa\u00adnies with sustainable growth poten\u00adtial, parti\u00adcu\u00adlarly in the digi\u00adtal, trans\u00adpor\u00adta\u00adtion and logi\u00adstics, indus\u00adtrial, and energy sectors.<\/p>\n
Manage\u00adment Consul\u00adtant for SK Pharma: POELLATH<\/strong><\/p>\n Dr. Bene\u00addikt Hohaus (Part\u00adner, Manage\u00adment Buyouts, M&A\/Private Equity) www.pplaw.de<\/p>\n","protected":false},"excerpt":{"rendered":" London\/Bielefeld \u2014 Arcus Infra\u00adstruc\u00adture Part\u00adners (\u201cArcus\u201d), an invest\u00adment firm specia\u00adli\u00adzing in infra\u00adstruc\u00adture invest\u00adments, has acqui\u00adred SK Pharma Logi\u00adstics GmbH (\u201cSK Pharma\u201d), a provi\u00adder of logi\u00adstics solu\u00adti\u00adons for the health\u00adcare indus\u00adtry in Germany, through its Arcus Euro\u00adpean Infra\u00adstruc\u00adture Fund 4. SK Pharma\u2019s exis\u00adting manage\u00adment team will retain a stake in the company. The tran\u00adsac\u00adtion is still [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":61023,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-61025","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\n
\nSilke Simmer, LL.M. (Coun\u00adsel, Manage\u00adment Buyouts, M&A\/Private Equity)
\nNata\u00adlie Tafel\u00adski (Asso\u00adciate, Manage\u00adment Buyouts, M&A\/Private Equity) <\/p>\n